CompletedNCT01135316
Prospective Evaluation of the Incidence of NSF in Patients With Kidney Disease Undergoing MR
Studying Nephrogenic systemic fibrosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Lantheus Medical Imaging
- Principal Investigator
- Simon P Robinson, PhDLantheus Medical Imaging
- Intervention
- Ablavar(drug)
- Enrollment
- 2 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2009 – 2013
Study locations (2)
- Weill Cornell Medical College, New York, New York, United States
- Duke University Medical Center, Durham, North Carolina, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01135316 on ClinicalTrials.gov